ArticleHepatitis monthly2015

Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1.

Heidar Sharafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.